Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030

Starting Price : $ 4000.00 $3200.00 | Pages : 442 | Published : October 2020 | SKU CODE : o&s171 | Format :

Request Sample

Oncology Drugs Market Definition

The oncology drugs market consists of sales of oncology drugs and related services by entities (organizations, sole traders and partnerships) that produce oncology drugs to diagnose and treat all types of cancers. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, kidney cancer, brain tumor, and other cancer types.

The pharmaceutical industry develops drugs to diagnose, treat or prevent diseases. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Oncology drug manufacturers produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

Oncology Drugs Market Size

The global oncology drugs market reached a value of nearly $167.9 billion in 2019, having increased at a compound annual growth rate (CAGR) of 9.8% since 2015.  The market is expected to decline from $167.9 billion in 2019 to $149.9 billion in 2020 at a rate of –11%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is expected to grow slightly from $201.1 billion in 2021 to $284.5 billion in 2023 at a CAGR of 9.7%.  The market is expected to stabilize and reach $284.5 billion in 2025 and $412.9 billion in 2030.

Growth in the historic period resulted from rapid growth in elderly population, strong economic growth in emerging markets, increased healthcare expenditure, increased number of approvals for hematology/oncology (cancer) drugs, increase in pharmaceutical R&D expenditure and advances in cancer drug discovery. Factors that negatively affected growth in the historic period were patent expiration of drugs, pricing pressures from regulators, challenges due to regulatory changes, and low healthcare access.

Going forward, increase in cancer incidence rate, rise in healthcare expenditure, increasing geriatric population, strong pipeline of drugs and revised FDA regulations to facilitate biologics drug development are expected to drive the market. High costs of drugs, rise in interest rates, rising popularity of alternative therapies and natural remedies, coronavirus pandemic, covid-19 impacting drug trails, and reduction in free trade are major factors that could hinder the growth of the oncology drugs market in the future.

Oncology Drugs Market Drivers

The key drivers of the oncology drugs market include:

Increase in Cancer Incidence Rate

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the oncology drugs market during the forecast period. According to American Cancer Society, there were 17,62,450 new cases and 6,06,880 cancer deaths in 2019 in the USA.  The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases.   Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for oncology drugs market over the forthcoming years.

Oncology Drugs Market Restraints

The key restraints on the oncology drugs market include:

Challenges Due To Regulatory Changes

Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to data protection such as the European Union`s General Data Protection Regulation (GDPR), changes to drug approval procedures and other regulatory changes. For instance, according to a report by Ernst and Young in 2018, Fortune 500 companies are spending $7.8 billion to comply with GDPR.   The GDPR is an EU law on privacy and data protection of individuals residing in the European Union and the European Economic Area (EEA). It also regulates data anonymization thus maintaining the integrity of data dealing with patients and other clinical trial studies. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the oncology drugs market.  

Oncology Drugs Market Trends

Major trends influencing the oncology drugs market include:

Development Of Personalized Cancer Vaccines

Drug manufacturers are investing in developing personalized cancer vaccines, and few have reached clinical trial phases. Pharmaceutical companies are combining genetic sequencing and precision medicine to create new drug therapies and cancer treatments that are designed to treat specific patients. For instance, in 2016, Merck, an American pharmaceutical company collaborated with Moderna Therapeutics, an American biotech company pioneer of messenger RNA Therapeutics to develop and commercialize novel messenger RNA (mRNA)-based personalized cancer vaccines. In 2019, Moderna announced the result from the ongoing Phase 1 clinical study in patients with both resected (adjuvant) and unresected (advanced) solid tumors. The results were positive when mRNA mRNA personalized cancer vaccine (PCV) mRNA-4157, given alone or in combination with Merck’s pembrolizumab (KEYTRUDA®). Currently the vaccine is in phase 2 clinical trial.

Use Of 3D Printing To Test New Oncology Drugs

Manufacturers of oncology drugs are investing in 3D printing devices that mimic the human body to test new oncology drugs, hence reducing the time taken for approval and reducing clinical patient trials. These 3D printed devices are cheap to produce and can be fabricated quickly and easily, thus saving time and cutting costs. This method also allows personalization of medicine, as an individual patient’s tumor may be replicated to create the device, and different treatment methods may be tested on the device until the most effective treatment option is found.   For example, Knight Cancer Institute is relying on San Diego based company, Organovo that designs three dimensional human tissues for medical research applications, for discovering and testing new cancer drugs.

Opportunities And Recommendations In The Oncology Drugs Market

Opportunities – The top opportunities in the oncology drugs market segmented by type will arise in the blood cancer segment, which will gain $15.3 billion of global annual sales by 2023. The top opportunities in the oncology drugs market segmented by drug class type will arise in the targeted therapy segment, which will gain $38.6 billion of global annual sales by 2023.The top opportunities in the oncology drugs market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $41.5 billion of global annual sales by 2023. The top opportunities in the oncology drugs market segmented by drug classification will arise in the branded drugs segment, which will gain $69.0 billion of global annual sales by 2023. The top opportunities in the oncology drugs market segmented by route of administration will arise in the parenteral segment, which will gain $31.7 billion of global annual sales by 2023. The oncology drugs market size will gain the most in the USA at $25.1 billion.

Market-trend-based strategies for the oncology drugs market include focus efforts towards the development of next-generation biologics, develop micro needle injectors-based drugs to increase the bioavailability, consider investing in immunotherapy drugs and  developing personalized oncology drugs to treat specific patients, should carry out strategic collaborations to boost innovations and should invest in AI solutions, to reduce R&D costs and save development times Player-adopted strategies in the oncology drugs market include strengthening its oncology drugs business by getting approvals of its drugs in different geographical region,  and expanding businesses through sustainable investments, and strengthening through collaboration.

Recommendations – To take advantage of these opportunities, The Business Research Company recommends the oncology drug manufacturing companies to consider investing in the development of the cell and gene therapies and microneedle pills, work on strategic alliances for research & development to speed-up the drug discovery and manufacturing process, expanding activities to emerging markets to gain market share, offer competitively priced products to attract the users and use direct-to-consumer (DTC) advertising and big data analytics to reach targeted audience, among other strategies.

Oncology Drugs Market Segmentation

The oncology drugs market is segmented by type of drug, by type drug class type, by distribution channel, by route of administration, by drug classification and by geography.
By Type - The oncology drugs market can be segmented by type into drugs for
    • a. Blood Cancer
    • b. Breast Cancer
    • c. Lung Cancer
    • d. Prostate cancer
    • e. Colorectal Cancer
    • f. Cervical cancer
    • g. Kidney cancer
    • h. Gastric Cancer
    • i. Brain Tumor
    • j. Skin Cancer
    • k. Ovarian Cancer
    • l. Bladder Cancer
    • m. Pancreatic Cancer
    • n. Thyroid cancer
    • o. Others
The blood cancer was the largest segment of the oncology drugs market by type, accounting for 19.0% of the total market in 2019. Going forward, ovarian cancer segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 21.0%.
By Drug Class Type – The oncology drugs market can be segmented by drug class type into
    • a. Targeted Therapy
    • b. Immunotherapy (Biologic Therapy)
    • c. Chemotherapy
    • d. Hormonal Therapy
The targeted therapy was the largest segment of the oncology drugs market by drug class type, accounting for 42.3% of the total market in 2019. Going forward, the chemotherapy segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 14.5%.
By Distribution Channel – The oncology drugs market can be segmented by distribution channel into
    • a. Retail Pharmacies/Drug Stores
    • b. Hospital Pharmacies
    • c. Others
The hospital pharmacies was the largest segment of the oncology drugs market by distribution channel, accounting for 50.8% of the total market in 2019. Going forward, the others segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 12.6%.
By Route Of Administration – The oncology drugs market can be segmented by route of administration into
    • a. Oral
    • b. Parenteral
    • c. Others
The parental was the largest segment of the oncology drugs market by route of administration, accounting for 53.5% of the total market in 2019. Going forward, the others segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 12.7%.
By Drug Classification – The oncology drugs market can be segmented by route of administration into
    • a. Branded
    • b. Generic
The branded drugs was the largest segment of the oncology drugs market by drug classification, accounting for 94.3% of the total market in 2019. Going forward, the generic drugs segment is expected to be the fastest growing segment in the oncology drugs market, at a CAGR of 11.8%.
By Geography– The oncology drugs market is segmented into
    • o North America
      • USA
      • Canada
      • Mexico
    • o Western Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Austria
      • Belgium
      • Denmark
      • Finland
      • Ireland
      • Netherlands
      • Norway
      • Portugal
      • Sweden
      • Switzerland
    • o Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • Indonesia
      • South Korea
      • Hong Kong
      • Malaysia
      • New Zealand
      • Philippines
      • Singapore
      • Thailand
      • Vietnam
    • o Eastern Europe
      • Russia
      • Czech Republic
      • Poland
      • Romania
    • o South America
      • Brazil
      • Argentina
      • Chile
      • Colombia
      • Peru
      • Venezuela
    • o Middle East
      • Israel
      • Saudi Arabia
      • Turkey
      • UAE
    • o Africa
      • Egypt
      • Nigeria
      • South Africa
North America was the largest region in the global oncology drugs market, accounting for 41.2% of the total in 2019. It was followed by the Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the oncology drugs market will be Asia Pacific and South America.

Oncology Drugs Competitive Landscape

Major Competitors are:
    • • F. Hoffmann-La Roche AG
    • • Novartis AG
    • • Bristol-Myers Squibb Company
    • • Merck & Co., Inc.
    • • Johnson & Johnson
Other Competitors Include:
    • • AbbVie Inc.
    • • Adcock Ingram
    • • AdoRx Therapeutics
    • • AID Genomics Limited
    • • Amgen
    • • Apikos Pharma
    • • AQVIDA GmbH
    • • Arlak Biotech
    • • Aspen
    • • Astellas Pharma Inc
    • • AstraZeneca plc
    • • Baxter International Inc.
    • • Bayer AG
    • • BeiGene
    • • BIOPHARMA-MEA
    • • Cambridge Cancer Genomics
    • • CARsgen Therapeutics
    • • Catalyst Clinical Research
    • • Celentyx
    • • Celgene Corporation
    • • Cellomatics BioSciences
    • • Celnova Pharma
    • • Chugai Pharmaceutical Co.Ltd
    • • Clovis Oncology
    • • CStone Pharma
    • • CureTech Ltd.
    • • Daiichi Pharmaceutical and Sankyo
    • • Eisai Co., Ltd.
    • • Eli Lilly and Company
    • • Eurofarma Laboratórios S.A.
    • • Eurolab
    • • F. Hoffmann-La Roche AG
    • • GlaxoSmithKline plc
    • • Healthkind Labs Pvt Ltd
    • • Johnson & Johnson
    • • Julphar
    • • JW Therapeutics
    • • Kitov Pharma Limited
    • • Kolaz biotech
    • • Kyowa Hakko Kirin
    • • Merck
    • • Merck Sharp & Dohme Corp. (Merck & Co., Inc.)
    • • Mitsubishi Tanabe Pharma Corporation
    • • Neopharma
    • • NeoTX
    • • Novartis AG
    • • Novo Nordisk A/S
    • • Otsuka Pharmaceutical Co., Ltd.
    • • Pfizer
    • • Pharmacyclics
    • • Pierre Fabre Group
    • • Sanofi
    • • Shionogi Co., Ltd.
    • • SwisscheM Healthcare Pvt.Ltd.
    • • Takeda Pharmaceuticals
    • • Teva Pharmaceutical Industries Ltd.
    • • TUTEUR Argentina

  1. 1. Oncology Drugs Market Executive Summary  
  2. 2. Table of Contents
  3. 3. List of Figures
  4. 4. List of Tables
  5. 5. Report Structure
  6. 6. Introduction
    • 6. 1. 1. Segmentation By Geography
    • 6. 1. 2. Segmentation By Type
    • 6. 1. 3. Segmentation By Drug Class Type
    • 6. 1. 4. Segmentation By Distribution Channel
    • 6. 1. 5. Segmentation By Route Of Administration
    • 6. 1. 6. Segmentation By Drug Classification
  7. 7. Oncology Drugs Market Characteristics
    • 7. 1. Market Definition
    • 7. 2. Market Segmentation By Type
      • 7. 2. 1. Lung Cancer Drugs
      • 7. 2. 2. Pancreatic Cancer Drugs
      • 7. 2. 3. Breast Cancer Drugs
      • 7. 2. 4. Prostate Cancer Drugs
      • 7. 2. 5. Ovarian Cancer Drugs
      • 7. 2. 6. Colorectal Cancer Drugs
      • 7. 2. 7. Gastric Cancer Drugs
      • 7. 2. 8. Kidney Cancer Drugs
      • 7. 2. 9. Brain Tumor Drugs
      • 7. 2. 10. Thyroid Cancer Drugs
      • 7. 2. 11. Skin Cancer Drugs
      • 7. 2. 12. Bladder Cancer Drugs
      • 7. 2. 13. Cervical Cancer Drugs
      • 7. 2. 14. Blood Cancer Drugs
      • 7. 2. 15. Others
    • 7. 3. Market Segmentation By Drug Class Type
      • 7. 3. 1. Chemotherapy
      • 7. 3. 2. Targeted Therapy
      • 7. 3. 3. Immunotherapy (Biologic Therapy)
      • 7. 3. 4. Hormonal Therapy
    • 7. 4. Market Segmentation By Distribution Channel
      • 7. 4. 1. Hospital Pharmacies
      • 7. 4. 2. Retail Pharmacies/Drug Stores
      • 7. 4. 3. Other Pharmacies
    • 7. 5. Market Segmentation By Route Of Administration
      • 7. 5. 1. Oral
      • 7. 5. 2. Parenteral
      • 7. 5. 3. Others
    • 7. 6. Market Segmentation By Drug Classification
      • 7. 6. 1. Branded Drugs
      • 7. 6. 2. Generic Drugs
  8. 8. Oncology Drugs Market, Supply Chain Analysis
    • 8. 1. Raw Material Suppliers
    • 8. 2. Contract Research Organization (CRO)
    • 8. 3. Oncology Drugs Manufacturer
      • 8. 3. 1. Drug Discovery
      • 8. 3. 2. Preclinical And Clinical Trials
      • 8. 3. 3. Patents Upon Discovery And Approval
      • 8. 3. 4. Drug Manufacturing
    • 8. 4. Contract Manufacturing Organization (CMO)
    • 8. 5. Wholesalers/Distributors
    • 8. 6. Retailers (Pharmacies) And Hospitals
    • 8. 7. Oncologists
    • 8. 8. End-Users
  9. 9. Oncology Drugs Market, Product Analysis – Product Examples
  10. 10. Oncology Drugs Market Customer Information
    • 10. 1. Cancer Patients Need More Knowledge On Their Treatment
    • 10. 2. COVID-19 Pandemic Effects On Cancer Patients and Survivors
    • 10. 3. Pharma Salespeople Are A Major Influence On Oncologists
    • 10. 4. Only 17% Of Cancer Patients Are Treated Right
    • 10. 5. Major Challenges To Future Cancer Program Growth
    • 10. 6. Americans Taking More Prescription Drugs than Ever
    • 10. 7. Dutch Patients Highly Satisfied With Information On Chemotherapy
  11. 11. Oncology Drugs Market Trends And Strategies
    • 11. 1. Development And Increasing Demand For Next Generation Biologics
    • 11. 2. Innovation in Patient Therapies (New Active Substances)
    • 11. 3. CRISPR-Cas9 Technology Use In Cancer Treatment
    • 11. 4. Expansion Of Cell And Gene Therapy & CAR-T Approvals
    • 11. 5. Microneedle Pills
    • 11. 6. Development Of Personalized Cancer Vaccines
    • 11. 7. Rising Focus On Immunotherapy Drugs For Cancer Treatment
    • 11. 8. Development Of New Drugs To Treat Blood Cancer
    • 11. 9. Collaboration Driving Innovation
    • 11. 10. Investment In Artificial Intelligence For Oncology Drugs
    • 11. 11. Use Of 3D Printing To Test New Oncology Drugs
    • 11. 12. Rising Focus On Targeted Therapy
    • 11. 13. Shift Towards Oral Chemotherapy Drugs
  12. 12. Leading Oncology Drug Therapies
    • 12. 1. Chemotherapy
    • 12. 2. Targeted Therapy
    • 12. 3. Immunotherapy (Biologic Therapy)
    • 12. 4. Hormonal Therapy
    • 12. 5. Radiation Therapy
  13. 13. Gene Therapy In Oncology
    • 13. 1. Artificial Cell Stimulation
    • 13. 2. Oncolytic Virotherapy
    • 13. 3. Gene Transfer
    • 13. 4. Others
  14. 14. Unmet Needs In Oncology Drugs
    • 14. 1. Novel Mechanism Of Action
    • 14. 2. Less Treatment Options Available For Rare Cancers
    • 14. 3. Unfavorable Benefits/Risk
    • 14. 4. Intractable Tumors
    • 14. 5. Intractable Tumors Subsets
    • 14. 6. Rare Or Unclassifiable Tumors
  15. 15. Oncology Drugs In Pipeline
  16. 16. Top 10 Drugs In The Global Oncology drugs Market
  17. 17. COVID Impact On The Oncology Drugs Market
    • 17. 1. Clinical Trial Delays
    • 17. 2. Low Usage Of Drugs
    • 17. 3. Supply Chain Issues
  18. 18. Global Oncology Drugs Market Size And Growth
    • 18. 1. Market Size
    • 18. 2. Historic Market Growth, 2015 – 2019, Value ($ Billion)
      • 18. 2. 1. Drivers Of The Market 2015 – 2019
      • 18. 2. 2. Restraints On The Market 2015 – 2019
    • 18. 3. Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
      • 18. 3. 1. Drivers Of The Market 2019 – 2023
      • 18. 3. 2. Restraints On The Market 2019 – 2023
  19. 19. Oncology Drugs Market, Regional Analysis
    • 19. 1. Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 19. 2. Global Oncology Drugs Market, 2015 – 2023, Historic And Forecast, By Region
    • 19. 3. Global Oncology Drugs Market, 2019-2023, Growth And Market Share Comparison, By Region
  20. 20. Global Oncology Drugs Market Segmentation
    • 20. 1. Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 20. 1. 1. Blood Cancer
      • 20. 1. 2. Breast Cancer
      • 20. 1. 3. Lung Cancer
      • 20. 1. 4. Prostate cancer
      • 20. 1. 5. Colorectal Cancer
      • 20. 1. 6. Cervical Cancer
      • 20. 1. 7. Kidney Cancer
      • 20. 1. 8. Gastric Cancer
      • 20. 1. 9. Brain Tumor
      • 20. 1. 10. Skin Cancer
      • 20. 1. 11. Ovarian Cancer
      • 20. 1. 12. Bladder Cancer
      • 20. 1. 13. Pancreatic Cancer
      • 20. 1. 14. Thyroid Cancer
      • 20. 1. 15. Others
    • 20. 2. Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 20. 2. 1. Targeted Therapy drugs
      • 20. 2. 2. Immunotherapy (Biologic Therapy) drugs
      • 20. 2. 3. Chemotherapy drugs
      • 20. 2. 4. Hormonal Therapy drugs
    • 20. 3. Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 20. 3. 1. Parenteral route of administration
      • 20. 3. 2. Oral route of administration
      • 20. 3. 3. Others route of administration
    • 20. 4. Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 20. 4. 1. Hospital Pharmacies distribution channel
      • 20. 4. 2. Retail Pharmacies/Drug Stores distribution channel
      • 20. 4. 3. Others distribution channel
    • 20. 5. Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 20. 5. 1. Branded
      • 20. 5. 2. Generic
  21. 21. Global Oncology Drugs Market Comparison with Macro Economic Factors
    • 21. 1. Oncology Drugs Market Size, Percentage Of GDP, Global
    • 21. 2. Per Capita Average Oncology Drugs Market Expenditure, Global
  22. 22. Global Oncology Drugs Market Metrics
    • 22. 1. Estimated Average Expenditure, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence, 2019, By Country
    • 22. 2. Estimated Average Expenditure, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence, 2019, By Region
  23. 23. Asia-Pacific Oncology Drugs Market
    • 23. 1. Asia-Pacific Oncology Drugs Market Overview
      • 23. 1. 1. Region Information
      • 23. 1. 2. COVID Impact
      • 23. 1. 3. Market Information
      • 23. 1. 4. Background Information
      • 23. 1. 5. New Drug Approvals
      • 23. 1. 6. Government Initiatives
      • 23. 1. 7. Regulations
      • 23. 1. 8. Regulatory Bodies
      • 23. 1. 9. Major Associations
      • 23. 1. 10. Taxes Levied
      • 23. 1. 11. Corporate Tax Structure
      • 23. 1. 12. Investment
      • 23. 1. 13. Major Companies
    • 23. 2. Asia-Pacific Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 3. Asia-Pacific Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 4. Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 23. 5. Asia-Pacific Oncology Drugs Market, 2019, By Country, Value ($ Billion)
    • 23. 6. Asia-Pacific Oncology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 23. 7. Asia-Pacific Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 23. 8. Asia-Pacific Oncology Drugs Market Metrics
      • 23. 8. 1. Per Capita Oncology Drugs Expenditure, 2019, Asia-Pacific Major Countries
    • 23. 9. Asia-Pacific Oncology Drugs Market: Country Analysis
    • 23. 10. Australia Oncology Drugs Market
    • 23. 11. Australia Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 12. Australia Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 13. Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 23. 14. China Oncology Drugs Market
    • 23. 15. China Oncology Drugs Market Overview
      • 23. 15. 1. Country Information
      • 23. 15. 2. COVID Impact
      • 23. 15. 3. Market Information
      • 23. 15. 4. Background Information
      • 23. 15. 5. New Drug Approvals
      • 23. 15. 6. Government Initiatives
      • 23. 15. 7. Regulations
      • 23. 15. 8. Regulatory Bodies
      • 23. 15. 9. Major Associations
      • 23. 15. 10. Taxes Levied
      • 23. 15. 11. Corporate Tax Structure
      • 23. 15. 12. Investment
      • 23. 15. 13. Major Companies
    • 23. 16. China Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 17. China Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 18. China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 23. 19. Hong Kong Oncology Drugs Market
    • 23. 20. Hong Kong Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 21. Hong Kong Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 22. India Oncology Drugs Market
    • 23. 23. India Oncology Drugs Market Overview
      • 23. 23. 1. Country Information
      • 23. 23. 2. COVID Impact
      • 23. 23. 3. Market Information
      • 23. 23. 4. Background Information
      • 23. 23. 5. New Drug Approvals
      • 23. 23. 6. Government Initiatives
      • 23. 23. 7. Regulations
      • 23. 23. 8. Regulatory Bodies
      • 23. 23. 9. Major Associations
      • 23. 23. 10. Taxes Levied
      • 23. 23. 11. Corporate Tax Structure
      • 23. 23. 12. Investments
      • 23. 23. 13. Major Companies
    • 23. 24. India Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 25. India Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 26. India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 23. 27. Indonesia Oncology Drugs Market
    • 23. 28. Indonesia Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 29. Indonesia Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 30. Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 23. 31. Japan Oncology Drugs Market
    • 23. 32. Japan Oncology Drugs Market Overview
      • 23. 32. 1. Region Information
      • 23. 32. 2. COVID Impact
      • 23. 32. 3. Market Information
      • 23. 32. 4. Background Information
      • 23. 32. 5. New Drug Approvals
      • 23. 32. 6. Government Initiatives
      • 23. 32. 7. Regulations
      • 23. 32. 8. Regulatory Bodies
      • 23. 32. 9. Major Associations
      • 23. 32. 10. Taxes Levied
      • 23. 32. 11. Corporate Tax Structure
      • 23. 32. 12. Investments
      • 23. 32. 13. Major Companies
    • 23. 33. Japan Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 34. Japan Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 35. Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 23. 36. Malaysia Oncology Drugs Market
    • 23. 37. Malaysia Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 38. Malaysia Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 39. New Zealand Oncology Drugs Market
    • 23. 40. New Zealand Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 41. New Zealand Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 42. Philippines Oncology Drugs Market
    • 23. 43. Philippines Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 44. Philippines Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 45. Singapore Oncology Drugs Market
    • 23. 46. Singapore Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 47. Singapore Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 48. South Korea Oncology Drugs Market
    • 23. 49. South Korea Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 50. South Korea Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 51. South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 23. 52. Thailand Oncology Drugs Market
    • 23. 53. Thailand Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 54. Thailand Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 23. 55. Vietnam Oncology Drugs Market
    • 23. 56. Vietnam Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 23. 57. Vietnam Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
  24. 24. Western Europe Oncology Drugs Market
    • 24. 1. Western Europe Oncology Drugs Market Overview
      • 24. 1. 1. Region Information
      • 24. 1. 2. COVID Impact
      • 24. 1. 3. Market Information
      • 24. 1. 4. Background Information
      • 24. 1. 5. New Drug Approvals
      • 24. 1. 6. Government Initiatives
      • 24. 1. 7. Regulations
      • 24. 1. 8. Regulatory Bodies
      • 24. 1. 9. Major Associations
      • 24. 1. 10. Taxes Levied
      • 24. 1. 11. Corporate Tax Structure
      • 24. 1. 12. Investment
      • 24. 1. 13. Major Companies
    • 24. 2. Western Europe Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 3. Western Europe Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 4. Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 24. 5. Western Europe Oncology Drugs Market, 2019, By Country, Value ($ Billion)
    • 24. 6. Western Europe Oncology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 24. 7. Western Europe Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 24. 8. Western Europe Oncology Drugs Market Metrics
      • 24. 8. 1. Per Capita Oncology Drugs Expenditure, 2019, Western Europe Major Countries
    • 24. 9. Western Europe Oncology Drugs Market: Country Analysis
    • 24. 10. Austria Oncology Drugs Market
    • 24. 11. Austria Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 12. Austria Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 13. Belgium Oncology Drugs Market
    • 24. 14. Belgium Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 15. Belgium Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 16. Denmark Oncology Drugs Market
    • 24. 17. Denmark Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 18. Denmark Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 19. Finland Oncology Drugs Market
    • 24. 20. Finland Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 21. Finland Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 22. France Oncology Drugs Market
    • 24. 23. France Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 24. France Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 25. France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 24. 26. Germany Oncology Drugs Market
    • 24. 27. Germany Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 28. Germany Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 29. Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 24. 30. Ireland Oncology Drugs Market
    • 24. 31. Ireland Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 32. Ireland Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 33. Italy Oncology Drugs Market
    • 24. 34. Italy Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 35. Italy Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 36. Netherlands Oncology Drugs Market
    • 24. 37. Netherlands Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 38. Netherlands Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 39. Norway Oncology Drugs Market
    • 24. 40. Norway Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 41. Norway Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 42. Portugal Oncology Drugs Market
    • 24. 43. Portugal Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 44. Portugal Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 45. Spain Oncology Drugs Market
    • 24. 46. Spain Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 47. Spain Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 48. Sweden Oncology Drugs Market
    • 24. 49. Sweden Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 50. Sweden Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 51. Switzerland Oncology Drugs Market
    • 24. 52. Switzerland Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 53. Switzerland Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 54. UK Oncology Drugs Market
    • 24. 55. UK Oncology Drugs Market Overview
      • 24. 55. 1. Country Information
      • 24. 55. 2. COVID Impact
      • 24. 55. 3. Market Information
      • 24. 55. 4. Background Information
      • 24. 55. 5. New Drug Approvals
      • 24. 55. 6. Government Initiatives
      • 24. 55. 7. Regulations
      • 24. 55. 8. Regulatory Bodies
      • 24. 55. 9. Major Associations
      • 24. 55. 10. Taxes Levied
      • 24. 55. 11. Corporate Tax Structure
      • 24. 55. 12. Investments
      • 24. 55. 13. Major Companies
    • 24. 56. UK Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 24. 57. UK Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 24. 58. UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  25. 25. Eastern Europe Oncology Drugs Market
    • 25. 1. Eastern Europe Oncology Drugs Market Overview
      • 25. 1. 1. Region Information
      • 25. 1. 2. Impact Of COVID-19
      • 25. 1. 3. Market Information
      • 25. 1. 4. Background Information
      • 25. 1. 5. New Drug Approvals
      • 25. 1. 6. Government Initiatives
      • 25. 1. 7. Regulations
      • 25. 1. 8. Regulatory Bodies
      • 25. 1. 9. Major Associations
      • 25. 1. 10. Taxes Levied
      • 25. 1. 11. Corporate Tax Structure
      • 25. 1. 12. Investments
      • 25. 1. 13. Major Companies
    • 25. 2. Eastern Europe Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 25. 3. Eastern Europe Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 25. 4. Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 25. 5. Eastern Europe Oncology Drugs Market, 2019, By Country, Value ($ Billion)
    • 25. 6. Eastern Europe Oncology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 25. 7. Eastern Europe Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 25. 8. Eastern Europe Oncology Drugs Market Metrics
      • 25. 8. 1. Per Capita Oncology Drugs Expenditure, 2019, Eastern Europe Major Countries
    • 25. 9. Eastern Europe Oncology Drugs Market: Country Analysis
    • 25. 10. Czech Republic Oncology Drugs Market
    • 25. 11. Czech Republic Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 25. 12. Czech Republic Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 25. 13. Poland Oncology Drugs Market
    • 25. 14. Poland Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 25. 15. Poland Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 25. 16. Romania Oncology Drugs Market
    • 25. 17. Romania Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 25. 18. Romania Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 25. 19. Russia Oncology Drugs Market
    • 25. 20. Russia Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 25. 21. Russia Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 25. 22. Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  26. 26. North America Oncology Drugs Market
    • 26. 1. North America Oncology Drugs Market Overview
      • 26. 1. 1. Region Information
      • 26. 1. 2. Impact Of COVID-19
      • 26. 1. 3. Market Information
      • 26. 1. 4. Background Information
      • 26. 1. 5. New Drug Approvals
      • 26. 1. 6. Government Initiatives
      • 26. 1. 7. Regulations
      • 26. 1. 8. Regulatory Bodies
      • 26. 1. 9. Major Associations
      • 26. 1. 10. Taxes Levied
      • 26. 1. 11. Corporate Tax Structure
      • 26. 1. 12. Investments
      • 26. 1. 13. Major Companies
    • 26. 2. North America Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 26. 3. North America Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 26. 4. North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 26. 5. North America Oncology Drugs Market, 2019, By Country, Value ($ Billion)
    • 26. 6. North America Oncology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 26. 7. North America Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 26. 8. North America Oncology Drugs Market Metrics
      • 26. 8. 1. Per Capita Oncology Drugs Expenditure, 2019, North America Major Countries
    • 26. 9. North America Oncology Drugs Market: Country Analysis
    • 26. 10. Canada Oncology Drugs Market
    • 26. 11. Canada Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 26. 12. Canada Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 26. 13. Mexico Oncology Drugs Market
    • 26. 14. Mexico Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 26. 15. Mexico Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 26. 16. USA Oncology Drugs Market
    • 26. 17. USA Oncology Drugs Market Overview
      • 26. 17. 1. Country Information
      • 26. 17. 2. Impact Of COVID-19
      • 26. 17. 3. Market Information
      • 26. 17. 4. Background Information
      • 26. 17. 5. New Drug Approvals
      • 26. 17. 6. Government Initiatives
      • 26. 17. 7. Regulations
      • 26. 17. 8. Regulatory Bodies
      • 26. 17. 9. Major Associations
      • 26. 17. 10. Corporate Tax Structure
      • 26. 17. 11. Investments
      • 26. 17. 12. Major Companies
    • 26. 18. USA Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 26. 19. USA Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 26. 20. USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  27. 27. South America Oncology Drugs Market
    • 27. 1. South America Oncology Drugs Market Overview
      • 27. 1. 1. Region Information
      • 27. 1. 2. COVID Impact
      • 27. 1. 3. Market Information
      • 27. 1. 4. Background Information
      • 27. 1. 5. New Drug Approvals
      • 27. 1. 6. Government Initiatives
      • 27. 1. 7. Regulations
      • 27. 1. 8. Regulatory Bodies
      • 27. 1. 9. Major Associations
      • 27. 1. 10. Taxes Levied
      • 27. 1. 11. Corporate Tax Structure
      • 27. 1. 12. Investments
      • 27. 1. 13. Major Companies
    • 27. 2. South America Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 27. 3. South America Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 27. 4. South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 27. 5. South America Oncology Drugs Market, 2019, By Country, Value ($ Billion)
    • 27. 6. South America Oncology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 27. 7. South America Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 27. 8. South America Oncology Drugs Market Metrics
      • 27. 8. 1. Per Capita Oncology Drugs Expenditure, 2019, South America Major Countries
    • 27. 9. South America Oncology Drugs Market: Country Analysis
    • 27. 10. Argentina Oncology Drugs Market
    • 27. 11. Argentina Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 27. 12. Argentina Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 27. 13. Brazil Oncology Drugs Market
    • 27. 14. Brazil Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 27. 15. Brazil Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 27. 16. Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 27. 17. Chile Oncology Drugs Market
    • 27. 18. Chile Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 27. 19. Chile Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 27. 20. Colombia Oncology Drugs Market
    • 27. 21. Colombia Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 27. 22. Colombia Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 27. 23. Peru Oncology Drugs Market
    • 27. 24. Peru Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 27. 25. Peru Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 27. 26. Venezuela Oncology Drugs Market
    • 27. 27. Venezuela Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 27. 28. Venezuela Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
  28. 28. Middle East Oncology Drugs Market
    • 28. 1. Middle East Oncology Drugs Market Overview
      • 28. 1. 1. Region Information
      • 28. 1. 2. Impact Of COVID-19
      • 28. 1. 3. Market Information
      • 28. 1. 4. Background Information
      • 28. 1. 5. New Drug Approvals
      • 28. 1. 6. Government Initiatives
      • 28. 1. 7. Regulations
      • 28. 1. 8. Regulatory Bodies
      • 28. 1. 9. Major Associations
      • 28. 1. 10. Taxes Levied
      • 28. 1. 11. Corporate Tax Structure
      • 28. 1. 12. Investments
      • 28. 1. 13. Major Companies
    • 28. 2. Middle East Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 28. 3. Middle East Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 28. 4. Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 28. 5. Middle East Oncology Drugs Market, 2019, By Country, Value ($ Billion)
    • 28. 6. Middle East Oncology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 28. 7. Middle East Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 28. 8. Middle East Oncology Drugs Market Metrics
      • 28. 8. 1. Per Capita Oncology Drugs Expenditure, 2019, Middle East Major Countries
    • 28. 9. Middle East Oncology Drugs Market: Country Analysis
    • 28. 10. Israel Oncology Drugs Market
    • 28. 11. Israel Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 28. 12. Israel Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 28. 13. Saudi Arabia Oncology Drugs Market
    • 28. 14. Saudi Arabia Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 28. 15. Saudi Arabia Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 28. 16. Turkey Oncology Drugs Market
    • 28. 17. Turkey Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 28. 18. Turkey Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 28. 19. UAE Oncology Drugs Market
    • 28. 20. UAE Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 28. 21. UAE Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
  29. 29. Africa Oncology Drugs Market
    • 29. 1. Africa Oncology Drugs Market Overview
      • 29. 1. 1. Region Information
      • 29. 1. 2. Impact Of COVID-19
      • 29. 1. 3. Market Information
      • 29. 1. 4. Background Information
      • 29. 1. 5. Government Initiatives
      • 29. 1. 6. Regulations
      • 29. 1. 7. Regulatory Bodies
      • 29. 1. 8. Major Associations
      • 29. 1. 9. Taxes Levied
      • 29. 1. 10. Corporate Tax Structure
      • 29. 1. 11. Investments
      • 29. 1. 12. Major Companies
    • 29. 2. Africa Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 29. 3. Africa Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 29. 4. Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 29. 5. Africa Oncology Drugs Market, 2019, By Country, Value ($ Billion)
    • 29. 6. Africa Oncology Drugs Market, 2015 – 2023, Historic And Forecast, By Country
    • 29. 7. Africa Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
    • 29. 8. Africa Oncology Drugs Market Metrics
      • 29. 8. 1. Per Capita Oncology Drugs Expenditure, 2019, Africa Major Countries
    • 29. 9. Africa Oncology Drugs Market: Country Analysis
    • 29. 10. Egypt Oncology Drugs Market
    • 29. 11. Egypt Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 29. 12. Egypt Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 29. 13. Nigeria Oncology Drugs Market
    • 29. 14. Nigeria Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 29. 15. Nigeria Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
    • 29. 16. South Africa Oncology Drugs Market
    • 29. 17. South Africa Oncology Drugs Market, Historic Market Growth, 2015 – 2019, Value ($ Billion)
    • 29. 18. South Africa Oncology Drugs Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Billion)
  30. 30. Global Oncology Drugs Market Competitive Landscape
    • 30. 1. Company Profiles
    • 30. 2. F. Hoffmann-La Roche AG
      • 30. 2. 1. Company Overview
      • 30. 2. 2. Products And Services
      • 30. 2. 3. Business Strategy
      • 30. 2. 4. Financial Overview
    • 30. 3. Novartis AG
      • 30. 3. 1. Company Overview
      • 30. 3. 2. Products And Services
      • 30. 3. 3. Business Strategy
      • 30. 3. 4. Financial Overview
    • 30. 4. Bristol-Myers Squibb Company
      • 30. 4. 1. Company Overview
      • 30. 4. 2. Products And Services
      • 30. 4. 3. Business Strategy
      • 30. 4. 4. Financial overview
    • 30. 5. Merck & Co. , Inc.
      • 30. 5. 1. Company Overview
      • 30. 5. 2. Products And Services
      • 30. 5. 3. Business Strategy
      • 30. 5. 4. Financial Overview
    • 30. 6. Johnson & Johnson
      • 30. 6. 1. Company Overview
      • 30. 6. 2. Products And Services
      • 30. 6. 3. Business Strategy
      • 30. 6. 4. Financial Overview
  31. 31. Key Mergers And Acquisitions In The Oncology Drugs Market
    • 31. 1. Gilead Sciences, Inc. Acquired 49. 9% Equity In Pionyr Immunotherapeutics Inc.
    • 31. 2. Mediolanum Farmaceutici Acquired ElsaLys Biotech
    • 31. 3. True North Acquired Minority Stake In Biocon Biologics Ltd.
    • 31. 4. PAG Acquired Stake In Hisun BioRay
    • 31. 5. Eli Lilly And Company Acquired Loxo Oncology, Inc.
    • 31. 6. Fuji Pharma Co. , Ltd. Acquired Stake In Alvotech
    • 31. 7. Bristol-Myers Squibb Acquired Celgene Corporation
    • 31. 8. Kashiv Pharma, LLC Acquired Adello Biologics
    • 31. 9. Takeda Pharmaceutical Company Limited Acquired Shire Plc
    • 31. 10. GlaxoSmithKline Plc Acquired Tesaro, Inc.
    • 31. 11. Mundipharma International Limited Acquired Cinfa Biotech
    • 31. 12. F. Hoffmann-La Roche AG Acquired Tusk Therapeutics Ltd
    • 31. 13. Eli Lilly And Company Acquired ARMO BioSciences, Inc.
    • 31. 14. Threshold Pharmaceuticals Merged With Molecular Templates, Inc.
    • 31. 15. Ipsen Acquired Oncology Assets From Merrimack Pharmaceuticals
    • 31. 16. Takeda Pharmaceutical Company Limited Acquired ARIAD Pharmaceuticals, Inc.
    • 31. 17. Sumitomo Dainippon Pharma Co. , Ltd. Acquired Tolero Pharmaceuticals, Inc.
    • 31. 18. Astellas Pharma Inc. Acquired GANYMED Pharmaceuticals AG
  32. 32. Market Background: Pharmaceutical Drugs Market
    • 32. 1. Pharmaceutical Drugs Market Characteristics
      • 32. 1. 1. Market Definition
      • 32. 1. 2. Segmentation By Type
    • 32. 2. Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2023, Value ($ Billion)
    • 32. 3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
    • 32. 4. Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast, By Region
  33. 33. Oncology Drugs Market Opportunities & Strategies
    • 33. 1. Global Oncology Drugs Market In 2023 – Countries Offering Most New Opportunities
    • 33. 2. Global Oncology Drugs Market In 2023 – Segments Offering Most New Opportunities
    • 33. 3. Global Oncology Drugs Market In 2023 – Growth Strategies
      • 33. 3. 1. Market Trend Based Strategies
      • 33. 3. 2. Competitor Strategies
  34. 34. Oncology Drugs Market, Conclusions And Recommendations
    • 34. 1. Conclusions
    • 34. 2. Recommendations
      • 34. 2. 1. Product
      • 34. 2. 2. Price
      • 34. 2. 3. Place
      • 34. 2. 4. Promotion
  35. 35. Appendix
    • 35. 1. Market Data Sources
    • 35. 2. NAICS Definitions Of Industry Covered In This Report
    • 35. 3. Research Methodology
    • 35. 4. Currencies
    • 35. 5. Research Inquiries
    • 35. 6. The Business Research Company
    • 35. 7. Copyright and Disclaimer

List Of Tables

    Table 1: Global Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 2: Global Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 3: Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 4: Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Oncology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Table 6: Global Oncology Drugs Market, 2019-2023, Growth And Market Share Comparison, By Region
  • Table 7: Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 8: Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 10: Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 12: Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 14: Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 16: Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Global Oncology Drugs Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2023
  • Table 18: Global Oncology Drugs Market, Per Capita Average Oncology Drugs Market Industry Expenditure, 2015 – 2023, ($)
  • Table 19: Estimated Average Expenditure, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence, 2019, By Country
  • Table 20: Estimated Average Expenditure, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence, 2019, By Country
  • Table 21: Asia-Pacific Oncology Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 22: Asia Pacific Oncology Drugs Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 23: Asia-Pacific Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 24: Asia-Pacific Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 25: Asia-Pacific Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 26: Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 27: Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 28: Asia-Pacific Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 29: Asia-Pacific Oncology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 30: Asia-Pacific Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 31: Asia-Pacific Per Capita Oncology Drugs Expenditure, By Country, 2019, $
  • Table 32: Australia Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 33: Australia Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 34: Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 35: Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 36: China Oncology Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 37: China Oncology Drugs Market, Population By Age Group, 2015-2023, Thousands
  • Table 38: China Oncology Drugs Market, Healthcare Services Market Size, 2015-2019, $ Billion
  • Table 39: China Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 40: China Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 41: China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 42: China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 43: Hong Kong Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 44: Hong Kong Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 45: India Oncology Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 46: India Oncology Drugs Market, Population By Age Group, 2015-2023, Thousands
  • Table 47: India Oncology Drugs Market, Healthcare Services Market Size, 2015-2019, $ Billion
  • Table 48: India Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 49: India Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 50: India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 51: India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 52: Indonesia Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 53: Indonesia Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 54: Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 55: Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 56: Japan Oncology Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 57: Japan Oncology Drugs Market, Population By Age Group, 2015-2023, Thousands
  • Table 58: Japan Oncology Drugs Market, Healthcare Services Market Size, 2015-2019, $ Billion
  • Table 59: Japan Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 60: Japan Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 61: Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 62: Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 63: Malaysia Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 64: Malaysia Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 65: New Zealand Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 66: New Zealand Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 67: Philippines Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 68: Philippines Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 69: Singapore Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 70: Singapore Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 71: South Korea Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 72: South Korea Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 73: South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 74: South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 75: Thailand Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 76: Thailand Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 77: Vietnam Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 78: Vietnam Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 79: Western Europe Oncology Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 80: Western Europe Oncology Drugs Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 81: Western Europe Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 82: Western Europe Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 83: Western Europe Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 84: Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 85: Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 86: Western Europe Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 87: Western Europe Oncology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 88: Western Europe Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 89: Western Europe Per Capita Oncology Drugs Expenditure, By Country, 2019, $
  • Table 90: Austria Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 91: Austria Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 92: Belgium Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 93: Belgium Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 94: Denmark Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 95: Denmark Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 96: Finland Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 97: Finland Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 98: France Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 99: France Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 100: France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 101: France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 102: Germany Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 103: Germany Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 104: Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 105: Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 106: Ireland Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 107: Ireland Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 108: Italy Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 109: Italy Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 110: Netherlands Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 111: Netherlands Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 112: Norway Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 113: Norway Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 114: Portugal Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 115: Portugal Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 116: Spain Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 117: Spain Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 118: Sweden Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 119: Sweden Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 120: Switzerland Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 121: Switzerland Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 122: UK Oncology Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 123: UK Oncology Drugs Market, Population By Age Group, 2015-2023, Thousands
  • Table 124: UK Oncology Drugs Market, Healthcare Services Market Size, 2015-2019, $ Billion
  • Table 125: UK Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 126: UK Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 127: UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 128: UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 129: Eastern Europe Oncology Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 130: Eastern Europe Oncology Drugs Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 131: Eastern Europe Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 132: Eastern Europe Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 133: Eastern Europe Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 134: Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 135: Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 136: Eastern Europe Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 137: Eastern Europe Oncology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 138: Eastern Europe Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 139: Eastern Europe Per Capita Oncology Drugs Expenditure, By Country, 2019, $
  • Table 140: Czech Republic Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 141: Czech Republic Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 142: Poland Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 143: Poland Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 144: Romania Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 145: Romania Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 146: Russia Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 147: Russia Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 148: Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 149: Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 150: North America Oncology Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 151: North America Oncology Drugs Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 152: North America Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 153: North America Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 154: North America Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 155: North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 156: North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 157: North America Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 158: North America Oncology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 159: North America Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 160: North America Per Capita Oncology Drugs Expenditure, By Country, 2019, $
  • Table 161: Canada Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 162: Canada Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 163: Mexico Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 164: Mexico Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 165: USA Oncology Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 166: USA Oncology Drugs Market, Population By Age Group, 2015-2023, Thousands
  • Table 167: USA Oncology Drugs Market, Healthcare Services Market Size, 2015-2019, $ Billion
  • Table 168: USA Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 169: USA Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 170: USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 171: USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 172: South America Oncology Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 173: South America Oncology Drugs Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 174: South America Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 175: South America Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 176: South America Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 177: South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 178: South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 179: South America Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 180: South America Oncology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 181: South America Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 182: South America Per Capita Oncology Drugs Expenditure, By Country, 2019, $
  • Table 183: Argentina Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 184: Argentina Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 185: Brazil Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 186: Brazil Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 187: Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 188: Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 189: Chile Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 190: Chile Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 191: Colombia Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 192: Colombia Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 193: Peru Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 194: Peru Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 195: Venezuela Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 196: Venezuela Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 197: Middle East Oncology Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 198: Middle East Oncology Drugs Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 199: Middle East Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 200: Middle East Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 201: Middle East Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 202: Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 203: Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 204: Middle East Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 205: Middle East Oncology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 206: Middle East Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 207: Middle East Per Capita Oncology Drugs Expenditure, By Country, 2019, $
  • Table 208: Israel Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 209: Israel Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 210: Saudi Arabia Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 211: Saudi Arabia Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 212: Turkey Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 213: Turkey Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 214: UAE Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 215: UAE Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 216: Africa Oncology Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 217: Africa Oncology Drugs Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 218: Africa Oncology Drugs Market, Healthcare Services Market Size, By Country, 2015-2019, $ Billion
  • Table 219: Africa Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 220: Africa Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 221: Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 222: Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 223: Africa Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 224: Africa Oncology Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 225: Africa Oncology Drugs Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 226: Africa Per Capita Oncology Drugs Expenditure, By Country, 2019, $
  • Table 227: Egypt Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 228: Egypt Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 229: Nigeria Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 230: Nigeria Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 231: South Africa Oncology Drugs Market, Historic, 2015 – 2019, $ Billion
  • Table 232: South Africa Oncology Drugs Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Billion
  • Table 233: Global Oncology Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 234: F. Hoffmann-La Roche AG – Financial Performance, 2015 – 2019, $ Billion
  • Table 235: Novartis AG – Financial Performance, 2015 – 2019, $ Billion
  • Table 236: Bristol-Myers Squibb Company –  Financial Performance, 2015 – 2019, $ Billion
  • Table 237: Merck & Co. – Financial Performance, 2015-2019, $ Billion
  • Table 238: Johnson & Johnson (J&J) – Financial Performance, 2015 – 2019, $ Billion
  • Table 239: Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 – 2023, $ Billion
  • Table 240: Global Pharmaceutical Drugs Market, 2019, Split By Region
  • Table 241: Global Pharmaceutical Drugs Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Table 242: Global Oncology Drugs Market Size Gain ($ Billion), 2019 – 2023, By Country
  • Table 243: Global Oncology Drugs Market Size Gain ($ Billion), Segmentation By Type, 2019 – 2023
  • Table 244: Global Oncology Drugs Market Size Gain ($ Billion), Segmentation By Drug Class Type, 2019 – 2023
  • Table 245: Global Oncology Drugs Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2019 – 2023
  • Table 246: Global Oncology Drugs Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2019 – 2023
  • Table 247: Global Oncology Drugs Market Size Gain ($ Billion), Segmentation By Drug Classification, 2019 – 2023

List Of Figures

    Figure 1: Global Oncology Drugs Market Segmentation By Type
  • Figure 2: Global Oncology Drugs Market Segmentation By Drug Class Type
  • Figure 3: Global Oncology Drugs Market Segmentation By Distribution Channel
  • Figure 4: Global Oncology Drugs Market Segmentation By Route Of Administration
  • Figure 5: Global Oncology Drugs Market Segmentation By Drug Classification
  • Figure 6: Market Supply Chain For Oncology Drugs
  • Figure 7: Global Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 8: Global Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 9: Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 10: Global Oncology Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, Split By Region
  • Figure 11: Global Oncology Drugs Market, 2019-2023, Growth And Market Share Comparison, By Region
  • Figure 12: Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 13: Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 14: Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 15: Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 16: Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 17: Asia-Pacific Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 18: Asia-Pacific Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 19: Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 20: Asia-Pacific Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 21: Asia-Pacific Oncology Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, By Country
  • Figure 22: Asia-Pacific Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • Figure 23: Australia Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 24: Australia Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 25: Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 26: China Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 27: China Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 28: China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 29: Hong Kong Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 30: Hong Kong Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 31: India Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 32: India Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 33: India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 34: Indonesia Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 35: Indonesia Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 36: Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 37: Japan Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 38: Japan Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 39: Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 40: Malaysia Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 41: Malaysia Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 42: New Zealand Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 43: New Zealand Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 44: Philippines Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 45: Philippines Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 46: Singapore Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 47: Singapore Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 48: South Korea Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 49: South Korea Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 50: South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 51: Thailand Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 52: Thailand Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 53: Vietnam Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 54: Vietnam Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 55: Western Europe Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 56: Western Europe Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 57: Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 58: Western Europe Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 59: Western Europe Oncology Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, By Country
  • Figure 60: Western Europe Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • Figure 61: Austria Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 62: Austria Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 63: Belgium Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 64: Belgium Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 65: Denmark Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 66: Denmark Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 67: Finland Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 68: Finland Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 69: France Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 70: France Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 71: France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 72: Germany Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 73: Germany Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 74: Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 75: Ireland Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 76: Ireland Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 77: Italy Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 78: Italy Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 79: Netherlands Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 80: Netherlands Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 81: Norway Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 82: Norway Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 83: Portugal Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 84: Portugal Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 85: Spain Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 86: Spain Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 87: Sweden Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 88: Sweden Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 89: Switzerland Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 90: Switzerland Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 91: UK Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 92: UK Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 93: UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 94: Eastern Europe Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 95: Eastern Europe Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 96: Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 97: Eastern Europe Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 98: Eastern Europe Oncology Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, By Country
  • Figure 99: Eastern Europe Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • Figure 100: Czech Republic Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 101: Czech Republic Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 102: Poland Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 103: Poland Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 104: Romania Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 105: Romania Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 106: Russia Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 107: Russia Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 108: Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 109: North America Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 110: North America Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 111: North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 112: North America Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 113: North America Oncology Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, By Country
  • Figure 114: North America Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • Figure 115: Canada Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 116: Canada Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 117: Mexico Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 118: Mexico Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 119: USA Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 120: USA Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 121: USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 122: South America Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 123: South America Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 124: South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 125: South America Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 126: South America Oncology Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, By Country
  • Figure 127: South America Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • Figure 128: Argentina Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 129: Argentina Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 130: Brazil Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 131: Brazil Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 132: Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 133: Chile Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 134: Chile Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 135: Colombia Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 136: Colombia Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 137: Peru Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 138: Peru Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 139: Venezuela Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 140: Venezuela Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 141: Middle East Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 142: Middle East Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 143: Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 144: Middle East Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 145: Middle East Oncology Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, By Country
  • Figure 146: Middle East Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • Figure 147: Israel Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 148: Israel Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 149: Saudi Arabia Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 150: Saudi Arabia Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 151: Turkey Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 152: Turkey Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 153: UAE Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 154: UAE Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 155: Africa Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 156: Africa Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 157: Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, %
  • Figure 158: Africa Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 159: Africa Oncology Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, By Country
  • Figure 160: Africa Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • Figure 161: Egypt Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 162: Egypt Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 163: Nigeria Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 164: Nigeria Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 165: South Africa Oncology Drugs Market, Historic, 2015 - 2019, $ Billion
  • Figure 166: South Africa Oncology Drugs Market, Forecast, 2019 - 2023, 2025F, 2030F, $ Billion
  • Figure 167: Global Oncology Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 168: F. Hoffmann-La Roche AG - Financial Performance, 2015 - 2019, $ Billion
  • Figure 169: Novartis AG - Financial Performance, 2015 - 2019, $ Billion
  • Figure 170 Bristol-Myers Squibb Company - Financial Performance, 2015 - 2019, $ Billion
  • Figure 171: Merck & Co. - Financial Performance, 2015-2019, $ Billion
  • Figure 172: Johnson & Johnson (J&J) - Financial Performance, 2015 - 2019, $ Billion
  • Figure 173: Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 - 2023, $ Billion
  • Figure 174: Global Pharmaceutical Drugs Market, 2019, Split By Region
  • Figure 175: Global Pharmaceutical Drugs Market, 2015 - 2023, Historic And Forecast Growth Rate, Split By Region
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)